CDC Clinical Guidance for Ebola in Pregnant Women (cdc.gov)

• CDC issues guidance for screening and managing pregnant women with EVD in U.S. hospitals
• Pregnant healthcare workers should not care for EVD patients
• EBOV RNA may persist in amniotic fluid and breast milk up to 32 days post-recovery

"On May 3, 2024, the CDC released clinical guidance for U.S. hospitals on screening and managing pregnant women suspected of or confirmed with Ebola virus disease (EVD). The guidance recommends excluding pregnant healthcare workers from caring for EVD patients and individualizing obstetric management. It notes that EBOV can cross the placenta, with RNA detectable in amniotic fluid and breast milk up to 32 days after maternal recovery, necessitating extended infection control precautions."